Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$47.00
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010)
Board on Health Care Services (HCS)
Board on Health Sciences Policy (HSP)
Food and Nutrition Board (FNB)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Appendix E: Workshop Agenda." Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: The National Academies Press, 2010.

Please select a format:

Page
306


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

1:30 pm	Existing Frameworks for Biomarker Qualification—PhRMA—James Mayne
2:00 pm	NIH Biomarker Qualification/Cancer Perspective—Arthur Schatzkin
2:30 pm	Risk Factor to Surrogate Endpoint Pathway—Philip Greenland
3:00 pm	Discussion
3:30 pm	BREAK
3:45 pm	Troponin—James de Lemos
4:15 pm	CRP and Inflammatory Markers—Christie Ballantyne
4:45 pm	HDL/LDL—Bryan Brewer
5:15 pm	Case Studies Discussion Speakers and Committee
5:45 pm	ADJOURN